Biologicals

Hepatitis

Hepatitis A vaccine

Title: Requirements for hepatitis A vaccines (inactivated); Adopted 1994, TRS No 858, Annex 2

Hepatitis B vaccines, DNA recombinant

Recommendations to Assure the Quality, Safety and Efficacy of Recombinant Hepatitis B Vaccines. Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4.

Hepatitis B vaccine, plasma

Hepatitis WHO Working Group on Hepatitis and HIV Diagnostic Kits

Expert Committee on Biological Standardization, Geneva, 17-21 November 2003

UPCOMING EVENTS

WHO Collaborating Centers on Standardization on Regulatory Evaluation of Vaccines & Biotherapeutic Products: 1st meeting, Geneva, 24-26 April 2012

WHO Workshop on implementing WHO Guidelines on evaluating similar biotherapeutic products (SBPs), Xiamen, China, 28-30 May 2012

WHO Informal Consultation on the revision of the recommendations to assure the Quality, Safety and Efficacy of biological products prepared by recombinant DNA technology, Xiamen, China, 31 May-1 June 2012

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971